Effect of miR-146a/bFGF/PEG-PEI Nanoparticles on Inflammation Response and Tissue Regeneration of Human Dental Pulp Cells

Biomed Res Int. 2016:2016:3892685. doi: 10.1155/2016/3892685. Epub 2016 Jan 24.

Abstract

Introduction: Inflammation in dental pulp cells (DPCs) initiated by Lipopolysaccharide (LPS) results in dental pulp necrosis. So far, whether there is a common system regulating inflammation response and tissue regeneration remains unknown. miR-146a is closely related to inflammation. Basic fibroblast growth factor (bFGF) is an important regulator for differentiation.

Methods: To explore the effect of miR-146a/bFGF on inflammation and tissue regeneration, polyethylene glycol-polyethyleneimine (PEG-PEI) was synthesized, and physical characteristics were analyzed by dynamic light scattering and gel retardation analysis. Cell absorption, transfection efficiency, and cytotoxicity were assessed. Alginate gel was combined with miR-146a/PEG-PEI nanoparticles and bFGF. Drug release ratio was measured by ultraviolet spectrophotography. Proliferation and odontogenic differentiation of DPCs with 1 μg/mL LPS treatment were determined. Results. PEG-PEI prepared at N/P 2 showed complete gel retardation and smallest particle size and zeta potential. Transfection efficiency of PEG-PEI was higher than lipo2000. Cell viability decreased as N/P ratio increased. Drug release rate amounted to 70% at the first 12 h and then maintained slow release afterwards. Proliferation and differentiation decreased in DPCs with LPS treatment, whereas they increased in miR-146a/bFGF gel group.

Conclusions: PEG-PEI is a promising vector for gene therapy. miR-146a and bFGF play critical roles in inflammation response and tissue regeneration of DPCs.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Cell Proliferation / drug effects
  • Dental Pulp / cytology*
  • Drug Carriers / chemistry
  • Fibroblast Growth Factor 2 / chemistry
  • Fibroblast Growth Factor 2 / pharmacokinetics
  • Fibroblast Growth Factor 2 / pharmacology*
  • Humans
  • Lipopolysaccharides / adverse effects
  • MicroRNAs / chemistry
  • MicroRNAs / pharmacokinetics
  • MicroRNAs / pharmacology*
  • Nanoparticles / chemistry*
  • Polyethylene Glycols / chemistry
  • Polyethyleneimine / chemistry
  • Pulpitis / chemically induced
  • Pulpitis / metabolism*
  • Regeneration / drug effects*
  • Young Adult

Substances

  • Drug Carriers
  • Lipopolysaccharides
  • MIRN146 microRNA, human
  • MicroRNAs
  • Fibroblast Growth Factor 2
  • Polyethylene Glycols
  • Polyethyleneimine